Lack of Effects of Cholecystokinin And Proglumide, Antagonist of Its Receptor, on Pancreatic Ductal Carcinogenesis Induced by N-Nitrosobis(2-Hydroxypropyl) Amine in Hamsters.
スポンサーリンク
概要
- 論文の詳細を見る
The effects on pancreatic carcinogenesis of cholecystokinin (CCK) and/or proglumide (PGL), antagonist of CCK receptor, were studied in male hamsters initiated with N-nitrosobis (2-hydroxypropyl) amine (BHP). The animals were initially given weekly 500mg BHP/kg body weight subcutaneous injections for 5 times. This was followed by 40IDU/kg body weight by subcutaneous injections of CCK 3 times a week and/or by 1.25% or 2.5% PGL in the diet for 30 weeks. Pancreatic lesions including duct epithelial cell hyperplasia and atypical hyperplasia, intraductal carcinomas, and invasive carcinomas were induced in all groups of hamsters given BHP. However, no significance influence of CCK and/or PGL on the induction of these lesions was observed. Furthermore, CCK and/or PGL did not affect DNA synthesis in their component cells as judged by BrdU immunohistochemistry.
- 日本毒性病理学会の論文
日本毒性病理学会 | 論文
- Hepatocellular Carcinoma with PIVKA-II Production in a Young Laboratory Monkey
- Latent Infection of Canine Herpes Virus in Laboratory Beagle Dogs
- Age-specific and Dose-dependent Retinal Dysplasia and Degeneration Induced by a Single Intraperitoneal Administration of N-Methyl-N-nitrosourea to Rats
- Inhibitory Effects of Octreotide Acetate, a Somatostatin Analog, on Spontaneous Chronic Pancreatitis in WBN/Kob Rats
- Rapid Screening for Chemopreventive Agents in Herbal Extracts in a PhIP Rat Model with DNA Adduct and Cell Proliferation as End-Points